Adherex Technologies (FENC) Competitors

$10.18 -0.54 (-5.04%)

Closing price 10/13/2026 04:00 PM Eastern

Extended Trading

$10.18 +0.01 (+0.05%)

As of 05:24 AM Eastern

FENC vs. ETON, PAHC, AVLN, LBRX, and CRON

Should you buy Adherex Technologies stock or one of its competitors? Adherex Technologies's main competitors and comparable companies include Eton Pharmaceuticals (ETON), Phibro Animal Health (PAHC), Avalyn Pharma (AVLN), LB Pharmaceuticals (LBRX), and Cronos Group (CRON). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "pharmaceuticals" industry.

How does Adherex Technologies compare to Eton Pharmaceuticals?

Eton Pharmaceuticals (NASDAQ:ETON) and Adherex Technologies (NASDAQ:FENC) are both small-cap healthcare companies, but which is the better business? We will contrast the two companies based on the strength of their earnings, institutional ownership, profitability, dividends, analyst recommendations, risk, media sentiment and valuation.

Eton Pharmaceuticals has higher revenue and earnings than Adherex Technologies. Adherex Technologies is trading at a lower price-to-earnings ratio than Eton Pharmaceuticals, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Eton Pharmaceuticals	$79.95M	19.06	-$4.60M	$0.38	140.34
Adherex Technologies	$44.64M	8.01	-$9.74M	-$0.13	N/A

Eton Pharmaceuticals has a net margin of 12.02% compared to Adherex Technologies' net margin of -6.09%. Eton Pharmaceuticals' return on equity of 40.13% beat Adherex Technologies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Eton Pharmaceuticals	12.02%	40.13%	12.37%
Adherex Technologies	-6.09%	-5.71%	-2.37%

27.9% of Eton Pharmaceuticals shares are held by institutional investors. Comparatively, 55.5% of Adherex Technologies shares are held by institutional investors. 16.5% of Eton Pharmaceuticals shares are held by company insiders. Comparatively, 10.7% of Adherex Technologies shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Eton Pharmaceuticals has a beta of 0.9, suggesting that its stock price is 10% less volatile than the broader market. Comparatively, Adherex Technologies has a beta of 1.23, suggesting that its stock price is 23% more volatile than the broader market.

Eton Pharmaceuticals currently has a consensus price target of $67.50, indicating a potential upside of 26.57%. Adherex Technologies has a consensus price target of $17.00, indicating a potential upside of 66.99%. Given Adherex Technologies' higher possible upside, analysts plainly believe Adherex Technologies is more favorable than Eton Pharmaceuticals.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Eton Pharmaceuticals	0 Sell rating(s)	2 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.67
Adherex Technologies	1 Sell rating(s)	1 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.50

In the previous week, Eton Pharmaceuticals had 2 more articles in the media than Adherex Technologies. MarketBeat recorded 3 mentions for Eton Pharmaceuticals and 1 mentions for Adherex Technologies. Adherex Technologies' average media sentiment score of 1.82 beat Eton Pharmaceuticals' score of 0.74 indicating that Adherex Technologies is being referred to more favorably in the news media.

Company	Overall Sentiment
Eton Pharmaceuticals	Positive
Adherex Technologies	Very Positive

Summary

Eton Pharmaceuticals beats Adherex Technologies on 10 of the 14 factors compared between the two stocks.

How does Adherex Technologies compare to Phibro Animal Health?

Adherex Technologies (NASDAQ:FENC) and Phibro Animal Health (NASDAQ:PAHC) are both small-cap healthcare companies, but which is the superior stock? We will contrast the two companies based on the strength of their media sentiment, dividends, profitability, valuation, institutional ownership, risk, earnings and analyst recommendations.

Phibro Animal Health has a net margin of 6.57% compared to Adherex Technologies' net margin of -6.09%. Phibro Animal Health's return on equity of 37.86% beat Adherex Technologies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Adherex Technologies	-6.09%	-5.71%	-2.37%
Phibro Animal Health	6.57%	37.86%	9.18%

Adherex Technologies presently has a consensus target price of $17.00, suggesting a potential upside of 66.99%. Phibro Animal Health has a consensus target price of $47.67, suggesting a potential upside of 29.49%. Given Adherex Technologies' higher possible upside, equities analysts clearly believe Adherex Technologies is more favorable than Phibro Animal Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Adherex Technologies	1 Sell rating(s)	1 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.50
Phibro Animal Health	0 Sell rating(s)	2 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.75

Phibro Animal Health has higher revenue and earnings than Adherex Technologies. Adherex Technologies is trading at a lower price-to-earnings ratio than Phibro Animal Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Adherex Technologies	$44.64M	8.01	-$9.74M	-$0.13	N/A
Phibro Animal Health	$1.52B	0.98	$99.72M	$2.44	15.09

In the previous week, Phibro Animal Health had 3 more articles in the media than Adherex Technologies. MarketBeat recorded 4 mentions for Phibro Animal Health and 1 mentions for Adherex Technologies. Adherex Technologies' average media sentiment score of 1.82 beat Phibro Animal Health's score of 0.59 indicating that Adherex Technologies is being referred to more favorably in the media.

Company	Overall Sentiment
Adherex Technologies	Very Positive
Phibro Animal Health	Positive

Adherex Technologies has a beta of 1.23, suggesting that its stock price is 23% more volatile than the broader market. Comparatively, Phibro Animal Health has a beta of 0.42, suggesting that its stock price is 58% less volatile than the broader market.

55.5% of Adherex Technologies shares are held by institutional investors. Comparatively, 99.3% of Phibro Animal Health shares are held by institutional investors. 10.7% of Adherex Technologies shares are held by company insiders. Comparatively, 48.5% of Phibro Animal Health shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Summary

Phibro Animal Health beats Adherex Technologies on 11 of the 16 factors compared between the two stocks.

How does Adherex Technologies compare to Avalyn Pharma?

Avalyn Pharma (NASDAQ:AVLN) and Adherex Technologies (NASDAQ:FENC) are both small-cap healthcare companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, analyst recommendations, valuation, profitability, dividends, earnings, media sentiment and risk.

55.5% of Adherex Technologies shares are held by institutional investors. 10.7% of Adherex Technologies shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Avalyn Pharma has a net margin of 0.00% compared to Adherex Technologies' net margin of -6.09%. Avalyn Pharma's return on equity of 0.00% beat Adherex Technologies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Avalyn Pharma	N/A	N/A	N/A
Adherex Technologies	-6.09%	-5.71%	-2.37%

Avalyn Pharma has higher earnings, but lower revenue than Adherex Technologies. Adherex Technologies is trading at a lower price-to-earnings ratio than Avalyn Pharma, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Avalyn Pharma	N/A	N/A	N/A	-$22.81	N/A
Adherex Technologies	$44.64M	8.01	-$9.74M	-$0.13	N/A

Avalyn Pharma presently has a consensus target price of $60.00, suggesting a potential upside of 152.74%. Adherex Technologies has a consensus target price of $17.00, suggesting a potential upside of 66.99%. Given Avalyn Pharma's stronger consensus rating and higher possible upside, equities analysts plainly believe Avalyn Pharma is more favorable than Adherex Technologies.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Avalyn Pharma	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	2 Strong Buy rating(s)	2.86
Adherex Technologies	1 Sell rating(s)	1 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.50

In the previous week, Avalyn Pharma had 1 more articles in the media than Adherex Technologies. MarketBeat recorded 2 mentions for Avalyn Pharma and 1 mentions for Adherex Technologies. Adherex Technologies' average media sentiment score of 1.82 beat Avalyn Pharma's score of 0.66 indicating that Adherex Technologies is being referred to more favorably in the news media.

Company	Overall Sentiment
Avalyn Pharma	Positive
Adherex Technologies	Very Positive

Summary

Avalyn Pharma beats Adherex Technologies on 7 of the 13 factors compared between the two stocks.

How does Adherex Technologies compare to LB Pharmaceuticals?

Adherex Technologies (NASDAQ:FENC) and LB Pharmaceuticals (NASDAQ:LBRX) are both small-cap healthcare companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, institutional ownership, risk, analyst recommendations, valuation, dividends, profitability and media sentiment.

LB Pharmaceuticals has a net margin of 0.00% compared to Adherex Technologies' net margin of -6.09%. Adherex Technologies' return on equity of -5.71% beat LB Pharmaceuticals' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Adherex Technologies	-6.09%	-5.71%	-2.37%
LB Pharmaceuticals	N/A	-25.92%	-24.68%

55.5% of Adherex Technologies shares are owned by institutional investors. 10.7% of Adherex Technologies shares are owned by insiders. Comparatively, 5.8% of LB Pharmaceuticals shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Adherex Technologies has higher revenue and earnings than LB Pharmaceuticals. Adherex Technologies is trading at a lower price-to-earnings ratio than LB Pharmaceuticals, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Adherex Technologies	$44.64M	8.01	-$9.74M	-$0.13	N/A
LB Pharmaceuticals	N/A	N/A	-$25.20M	-$3.44	N/A

Adherex Technologies presently has a consensus target price of $17.00, indicating a potential upside of 66.99%. LB Pharmaceuticals has a consensus target price of $57.40, indicating a potential upside of 64.99%. Given Adherex Technologies' higher possible upside, equities research analysts plainly believe Adherex Technologies is more favorable than LB Pharmaceuticals.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Adherex Technologies	1 Sell rating(s)	1 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.50
LB Pharmaceuticals	1 Sell rating(s)	1 Hold rating(s)	10 Buy rating(s)	0 Strong Buy rating(s)	2.75

In the previous week, LB Pharmaceuticals had 13 more articles in the media than Adherex Technologies. MarketBeat recorded 14 mentions for LB Pharmaceuticals and 1 mentions for Adherex Technologies. Adherex Technologies' average media sentiment score of 1.82 beat LB Pharmaceuticals' score of 0.63 indicating that Adherex Technologies is being referred to more favorably in the media.

Company	Overall Sentiment
Adherex Technologies	Very Positive
LB Pharmaceuticals	Positive

Summary

Adherex Technologies beats LB Pharmaceuticals on 9 of the 13 factors compared between the two stocks.

How does Adherex Technologies compare to Cronos Group?

Cronos Group (NASDAQ:CRON) and Adherex Technologies (NASDAQ:FENC) are both small-cap healthcare companies, but which is the better investment? We will compare the two companies based on the strength of their valuation, profitability, institutional ownership, risk, earnings, dividends, media sentiment and analyst recommendations.

Cronos Group has higher revenue and earnings than Adherex Technologies. Adherex Technologies is trading at a lower price-to-earnings ratio than Cronos Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cronos Group	$146.59M	8.05	-$9.45M	$0.20	16.00
Adherex Technologies	$44.64M	8.01	-$9.74M	-$0.13	N/A

In the previous week, Cronos Group had 9 more articles in the media than Adherex Technologies. MarketBeat recorded 10 mentions for Cronos Group and 1 mentions for Adherex Technologies. Adherex Technologies' average media sentiment score of 1.82 beat Cronos Group's score of 0.53 indicating that Adherex Technologies is being referred to more favorably in the news media.

Company	Overall Sentiment
Cronos Group	Positive
Adherex Technologies	Very Positive

Cronos Group currently has a consensus target price of $2.30, suggesting a potential downside of 28.13%. Adherex Technologies has a consensus target price of $17.00, suggesting a potential upside of 66.99%. Given Adherex Technologies' higher possible upside, analysts clearly believe Adherex Technologies is more favorable than Cronos Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cronos Group	0 Sell rating(s)	2 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.60
Adherex Technologies	1 Sell rating(s)	1 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.50

Cronos Group has a beta of 0.9, meaning that its stock price is 10% less volatile than the broader market. Comparatively, Adherex Technologies has a beta of 1.23, meaning that its stock price is 23% more volatile than the broader market.

Cronos Group has a net margin of 39.08% compared to Adherex Technologies' net margin of -6.09%. Cronos Group's return on equity of 4.85% beat Adherex Technologies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Cronos Group	39.08%	4.85%	4.62%
Adherex Technologies	-6.09%	-5.71%	-2.37%

8.7% of Cronos Group shares are owned by institutional investors. Comparatively, 55.5% of Adherex Technologies shares are owned by institutional investors. 7.8% of Cronos Group shares are owned by insiders. Comparatively, 10.7% of Adherex Technologies shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Summary

Cronos Group beats Adherex Technologies on 9 of the 15 factors compared between the two stocks.

Get Adherex Technologies News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding FENC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

FENC vs. The Competition

Export

Metric	Adherex Technologies	Pharmaceuticals Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$376.68M	$12.36B	$7.26B	$13.21B
Dividend Yield	N/A	2.63%	2.52%	22.89%
P/E Ratio	N/A	637.87	201.05	19.53
Price / Sales	8.01	748.85	561.79	81.34
Price / Cash	N/A	86.65	77.16	53.04
Price / Book	9.79	9.20	10.77	6.03
Net Income	-$9.74M	$2.83B	$3.50B	$380.34M
7 Day Performance	-1.74%	-3.44%	-2.89%	-2.34%
1 Month Performance	-5.04%	-7.50%	-7.37%	-5.31%
1 Year Performance	23.10%	-5.64%	2.99%	-2.94%

Adherex Technologies Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
FENC Adherex Technologies	4.4797 of 5 stars	$10.18 -5.0%	$17.00 +67.0%	+20.6%	$376.68M	$44.64M	N/A	35	Positive News
ETON Eton Pharmaceuticals	4.2917 of 5 stars	$51.98 +1.0%	$67.50 +29.9%	+195.0%	$1.47B	$79.95M	136.79	44	High Trading Volume
PAHC Phibro Animal Health	4.5135 of 5 stars	$35.87 +0.4%	$47.67 +32.9%	+0.6%	$1.45B	$1.52B	14.70	2,605
AVLN Avalyn Pharma	2.3742 of 5 stars	$27.42 -3.8%	$60.00 +118.8%	N/A	$1.26B	N/A	N/A	55
LBRX LB Pharmaceuticals	2.465 of 5 stars	$37.28 -2.9%	$49.63 +33.1%	+116.5%	$1.24B	N/A	N/A	27	Analyst Upgrade

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:FENC) was last updated on 10/14/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Adherex Technologies (FENC) Competitors

FENC vs. ETON, PAHC, AVLN, LBRX, and CRON

How does Adherex Technologies compare to Eton Pharmaceuticals?

Summary

How does Adherex Technologies compare to Phibro Animal Health?

Summary

How does Adherex Technologies compare to Avalyn Pharma?

Summary

How does Adherex Technologies compare to LB Pharmaceuticals?

Summary

How does Adherex Technologies compare to Cronos Group?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

FENC vs. The Competition

Adherex Technologies Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Adherex Technologies (FENC) Competitors

FENC vs. ETON, PAHC, AVLN, LBRX, and CRON

How does Adherex Technologies compare to Eton Pharmaceuticals?

Which has preferable valuation & earnings, ETON or FENC?

Is ETON or FENC more profitable?

Do insiders and institutionals hold more shares of ETON or FENC?

Which has more risk and volatility, ETON or FENC?

Do analysts recommend ETON or FENC?

Does the media prefer ETON or FENC?

Summary

How does Adherex Technologies compare to Phibro Animal Health?

Is FENC or PAHC more profitable?

Do analysts rate FENC or PAHC?

Which has higher valuation and earnings, FENC or PAHC?

Does the media favor FENC or PAHC?

Which has more risk and volatility, FENC or PAHC?

Do insiders & institutionals have more ownership in FENC or PAHC?

Summary

How does Adherex Technologies compare to Avalyn Pharma?

Do institutionals & insiders hold more shares of AVLN or FENC?

Is AVLN or FENC more profitable?

Which has higher earnings and valuation, AVLN or FENC?

Do analysts rate AVLN or FENC?

Does the media refer more to AVLN or FENC?

Summary

How does Adherex Technologies compare to LB Pharmaceuticals?

Is FENC or LBRX more profitable?

Do institutionals and insiders believe in FENC or LBRX?

Which has preferable earnings and valuation, FENC or LBRX?

Do analysts rate FENC or LBRX?

Does the media prefer FENC or LBRX?

Summary

How does Adherex Technologies compare to Cronos Group?

Which has higher valuation and earnings, CRON or FENC?

Does the media favor CRON or FENC?

Do analysts recommend CRON or FENC?

Which has more risk & volatility, CRON or FENC?

Is CRON or FENC more profitable?

Do institutionals & insiders hold more shares of CRON or FENC?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

FENC vs. The Competition

Adherex Technologies Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools